+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Alfadolone Market by Form (Liquid, Powder), End-User (Specialty Clinics, Veterinary Hospitals) - Forecast 2024-2030- Product Image
Global Alfadolone Market by Form (Liquid, Powder), End-User (Specialty Clinics, Veterinary Hospitals) - Forecast 2024-2030- Product Image
Sale

Global Alfadolone Market by Form (Liquid, Powder), End-User (Specialty Clinics, Veterinary Hospitals) - Forecast 2024-2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968419
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Alfadolone Market size was estimated at USD 73.84 million in 2023, USD 78.31 million in 2024, and is expected to grow at a CAGR of 6.26% to reach USD 113.02 million by 2030.

Alfadolone is a type of pharmaceutical compound known as a neuroactive steroid. It functions primarily as an anesthetic, which is used to induce loss of sensation, especially to alleviate pain during surgical procedures. Alfadolone works by enhancing the effect of a neurotransmitter called GABA (gamma-aminobutyric acid) on its receptor in the brain. Increasing investment and development in veterinary healthcare facilities drive the demand for effective anesthetics, including alfadolone. As pet ownership rises and the care standards for animals in domestic and professional settings improve, the need for such drugs is increasing, driving the market growth.

Rising approvals from veterinary drug regulatory authorities across different regions to expand the adoption of alfadolone in practice is expanding the market growth. The availability and development of newer, possibly more effective, or safer alternative anesthetic agents restrain the growth of alfadolone’s market. Innovations and research in pharmaceuticals that lead to safer, more effective anesthesia solutions that drive the use and development of alfadolone are expected to create opportunities for market growth. Its effectiveness in rapid onset and short duration of anesthesia makes it favorable in fast-paced or emergency veterinary settings.

Regional Insights

In the Americas, alfadolone is a pivotal market due to its advanced healthcare infrastructure and sizable investment in medical research, which facilitates the adoption of new pharmaceuticals such as Alfadolone. Regulatory frameworks by agencies including, the FDA ensure stringent scrutiny of drugs, influencing market dynamics around drug approval and usage. South American countries are progressively catching up, with Brazil and Mexico leading due to their expanding healthcare sectors and increasing awareness about modern anesthetic drugs. The APAC region shows significant diversity in the Alfadolone market.

Economically advanced countries such as Japan, Australia, and South Korea have robust healthcare systems comparable to Western standards, supporting strong market growth. Conversely, in densely populated countries such as India and China, rapid urbanization and growing healthcare expenditures contribute to the market's expansion, albeit challenges including, regulatory diversity and price sensitivity remain. The region also sees variations in healthcare policy and access, influencing alfadolone’s market penetration. In Europe, a well-established healthcare infrastructure combined with strong regulatory frameworks including, those from the European Medicines Agency supports a steady market for Alfadolone. Countries such as Germany, the UK, and France lead in pharmaceutical consumption, including advanced anesthetics. The Middle East, shows growth potential, particularly in affluent nations including, the UAE and Saudi Arabia, where healthcare spending is rising. Africa presents a more complex scenario with a generally nascent healthcare infrastructure and varying regulatory environments.

Market Trends by Segment

  • Form: Growing usage of the liquid form of alfadolone due to its convenience in handling and application
  • End-User: High potential of alfadolone across veterinary hospitals as they requires reliable anesthesia products

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Expansion of Clemson University's College of Veterinary Medicine with Enhanced Budget Approval

Clemson University is progressing with developing its new College of Veterinary Medicine, with a planned opening in 2026. The university received increased budgetary support, with the total allocation rising to USD 110,466,000 after the South Carolina State approved additional funds for FY23 and FY24. This enhancement follows an initial USD 10 million granted for Phase 1 of the project, underscoring a significant investment in the educational infrastructure.

Key Company Profiles

The report delves into recent significant developments in the Alfadolone Market, highlighting leading vendors and their innovative profiles. These include Alfa Chemistry, Aquigen Bio Sciences Pvt. Ltd., LGC Limited, Pharmaffiliates Analytics and Synthetics P. Ltd., and Zoetis Services LLC.

This research report offers invaluable insights into various crucial aspects of the Alfadolone Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of surgical procedures
5.1.1.2. Increased demand for effective anesthetics
5.1.2. Restraints
5.1.2.1. Concerns related to product recalls and safety
5.1.3. Opportunities
5.1.3.1. Advancements in production and scalability technologies for faster availability
5.1.3.2. Collaborative development and public-private partnerships among pharmaceutical companies and government-backed research centers
5.1.4. Challenges
5.1.4.1. Counterfeit drug concerns
5.2. Market Segmentation Analysis
5.2.1. Form: Growing usage of the liquid form of alfadolone due to its convenience in handling and application
5.2.2. End-User: High potential of alfadolone across veterinary hospitals as they requires reliable anesthesia products
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Alfadolone Market, by Form
6.1. Introduction
6.2. Liquid
6.3. Powder
7. Alfadolone Market, by End-User
7.1. Introduction
7.2. Specialty Clinics
7.3. Veterinary Hospitals
8. Americas Alfadolone Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Alfadolone Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Alfadolone Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. Expansion of Clemson University's College of Veterinary Medicine with Enhanced Budget Approval
11.4. Strategy Analysis & Recommendation
12. Competitive Portfolio
12.1. Key Company Profiles
12.2. Key Product Portfolio
List of Figures
FIGURE 1. ALFADOLONE MARKET RESEARCH PROCESS
FIGURE 2. ALFADOLONE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ALFADOLONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ALFADOLONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ALFADOLONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ALFADOLONE MARKET DYNAMICS
FIGURE 7. GLOBAL ALFADOLONE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ALFADOLONE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALFADOLONE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ALFADOLONE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ALFADOLONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ALFADOLONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ALFADOLONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ALFADOLONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ALFADOLONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ALFADOLONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ALFADOLONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALFADOLONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ALFADOLONE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 20. ALFADOLONE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ALFADOLONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ALFADOLONE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ALFADOLONE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ALFADOLONE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ALFADOLONE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ALFADOLONE MARKET SIZE, BY LIQUID, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ALFADOLONE MARKET SIZE, BY LIQUID, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ALFADOLONE MARKET SIZE, BY POWDER, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ALFADOLONE MARKET SIZE, BY POWDER, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ALFADOLONE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ALFADOLONE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ALFADOLONE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ALFADOLONE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. AMERICAS ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 20. AMERICAS ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 21. AMERICAS ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 22. AMERICAS ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 23. AMERICAS ALFADOLONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 24. AMERICAS ALFADOLONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 25. ARGENTINA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 26. ARGENTINA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 27. ARGENTINA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 28. ARGENTINA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 29. BRAZIL ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 30. BRAZIL ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 31. BRAZIL ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 32. BRAZIL ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 33. CANADA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 34. CANADA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 35. CANADA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 36. CANADA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 37. MEXICO ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 38. MEXICO ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 39. MEXICO ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. MEXICO ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. UNITED STATES ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 42. UNITED STATES ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 43. UNITED STATES ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 44. UNITED STATES ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 45. UNITED STATES ALFADOLONE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 46. UNITED STATES ALFADOLONE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 48. ASIA-PACIFIC ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 50. ASIA-PACIFIC ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC ALFADOLONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 52. ASIA-PACIFIC ALFADOLONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 53. AUSTRALIA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 54. AUSTRALIA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 55. AUSTRALIA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 56. AUSTRALIA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 57. CHINA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 58. CHINA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 59. CHINA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. CHINA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. INDIA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 62. INDIA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 63. INDIA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 64. INDIA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 65. INDONESIA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 66. INDONESIA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 67. INDONESIA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. INDONESIA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. JAPAN ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 70. JAPAN ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 71. JAPAN ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. JAPAN ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. MALAYSIA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 74. MALAYSIA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 75. MALAYSIA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. MALAYSIA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. PHILIPPINES ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 78. PHILIPPINES ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 79. PHILIPPINES ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 80. PHILIPPINES ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 81. SINGAPORE ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 82. SINGAPORE ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 83. SINGAPORE ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 84. SINGAPORE ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 85. SOUTH KOREA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 86. SOUTH KOREA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 87. SOUTH KOREA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. SOUTH KOREA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. TAIWAN ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 90. TAIWAN ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 91. TAIWAN ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. TAIWAN ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. THAILAND ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 94. THAILAND ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 95. THAILAND ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. THAILAND ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. VIETNAM ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 98. VIETNAM ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 99. VIETNAM ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. VIETNAM ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ALFADOLONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ALFADOLONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 107. DENMARK ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 108. DENMARK ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 109. DENMARK ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. DENMARK ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. EGYPT ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 112. EGYPT ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 113. EGYPT ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 114. EGYPT ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 115. FINLAND ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 116. FINLAND ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 117. FINLAND ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. FINLAND ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. FRANCE ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 120. FRANCE ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 121. FRANCE ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. FRANCE ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. GERMANY ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 124. GERMANY ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 125. GERMANY ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 126. GERMANY ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 127. ISRAEL ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 128. ISRAEL ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 129. ISRAEL ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. ISRAEL ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. ITALY ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 132. ITALY ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 133. ITALY ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. ITALY ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. NETHERLANDS ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 136. NETHERLANDS ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 137. NETHERLANDS ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 138. NETHERLANDS ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 139. NIGERIA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 140. NIGERIA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 141. NIGERIA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. NIGERIA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. NORWAY ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 144. NORWAY ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 145. NORWAY ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. NORWAY ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. POLAND ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 148. POLAND ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 149. POLAND ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. POLAND ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. QATAR ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 152. QATAR ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 153. QATAR ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. QATAR ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. RUSSIA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 156. RUSSIA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 157. RUSSIA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 158. RUSSIA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 160. SAUDI ARABIA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. SAUDI ARABIA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 164. SOUTH AFRICA ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. SOUTH AFRICA ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. SPAIN ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 168. SPAIN ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 169. SPAIN ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. SPAIN ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. SWEDEN ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 172. SWEDEN ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 173. SWEDEN ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. SWEDEN ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. SWITZERLAND ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 176. SWITZERLAND ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 177. SWITZERLAND ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 178. SWITZERLAND ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 179. TURKEY ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 180. TURKEY ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 181. TURKEY ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. TURKEY ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ALFADOLONE MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 188. UNITED KINGDOM ALFADOLONE MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ALFADOLONE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. UNITED KINGDOM ALFADOLONE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. ALFADOLONE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 192. ALFADOLONE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Alfa Chemistry
  • Aquigen Bio Sciences Pvt. Ltd.
  • LGC Limited
  • Pharmaffiliates Analytics and Synthetics P. Ltd.
  • Zoetis Services LLC.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 78.31 Million
Forecasted Market Value ( USD ) by 2030 $ 113.02 Million
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned5

Related Topics

Related Reports

Alfadolone (CAS 14107-37-0) Global Market Research Report 2024 - Product Image

Alfadolone (CAS 14107-37-0) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Pregabalin Market by Dosage Forms (Extended Release, Oral Capsule, Oral Solution), Drug Class (Anticonvulsants, Fibromyalgia Agents), Application, End-Users, Distribution Channel - Forecast 2024-2030 - Product Image

Global Pregabalin Market by Dosage Forms (Extended Release, Oral Capsule, Oral Solution), Drug Class (Anticonvulsants, Fibromyalgia Agents), Application, End-Users, Distribution Channel - Forecast 2024-2030

  • Report
  • 184 Pages
  • Global
From
Global Etizolam Market by Form (Powders, Solutions, Tablet), Applications (Anxiety, Insomnia, Panic Disorders) - Forecast 2024-2030 - Product Image

Global Etizolam Market by Form (Powders, Solutions, Tablet), Applications (Anxiety, Insomnia, Panic Disorders) - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report by Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy), Drug Class (NSAIDs, Capsaicin, Opioid), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report by Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy), Drug Class (NSAIDs, Capsaicin, Opioid), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Global Cannabidiol Market Size, Share & Trends Analysis Report by Source Type (Hemp, Marijuana), Sales Type (B2B, B2C), End-use (Medical, Personal Use), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Cannabidiol Market Size, Share & Trends Analysis Report by Source Type (Hemp, Marijuana), Sales Type (B2B, B2C), End-use (Medical, Personal Use), Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From

About the Alfadolone Market

Alfadolone is a type of central nervous system (CNS) drug used to treat a variety of conditions, including anxiety, depression, and insomnia. It is a synthetic derivative of the naturally occurring hormone melatonin, and is believed to act on the brain's serotonin and melatonin receptors. Alfadolone is available in both oral and intravenous forms, and is often prescribed in combination with other CNS drugs. Alfadolone is generally well-tolerated, with few side effects. Common side effects include headache, nausea, and dizziness. It is important to note that Alfadolone can interact with other medications, and should not be taken without consulting a doctor. The Alfadolone market is a rapidly growing sector of the CNS drug market. It is increasingly being used to treat a variety of conditions, and is becoming more widely available. Some companies in the Alfadolone market include Pfizer, Novartis, and Merck. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.